BioSpace News Archive

Business

Mirati Therapeutics Reports First Quarter 2020 Financial Results And Recent Corporate Updates

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, reported financial results and a corporate update for the first quarter ended March 31, 2020.

May 7, 2020
·
9 min read
Business

Cryoport Revenue Grows 47% for First Quarter 2020

Revenue from commercial therapies increased 110% over the prior year

May 7, 2020
·
13 min read
Business

CTI BioPharma Reports First Quarter 2020 Financial Results

CTI BioPharma Corp. reported its financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
5 min read
Business

Cutera, Inc. Announces First Quarter 2020 Financial Results

Cutera, Inc., a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, reported financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
9 min read
Business

Insulet Reports First Quarter 2020 Revenue Increase of 24% Year-Over-Year

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced financial results for the three months ended March 31, 2020.

May 7, 2020
·
12 min read
Business

Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company focused on novel and targeted oncology therapies, announced financial results for the three-month period ended March 31, 2020.

May 7, 2020
·
8 min read
Business

Dicerna Announces Appointment of Douglas Pagán as Chief Financial Officer

Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference therapeutics, announced that Douglas Pagán will become Dicerna’s chief financial officer and a member of the Company’s executive leadership team, effective May 26, 2020.

May 7, 2020
·
5 min read
Business

Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results

Arrowhead Pharmaceuticals Inc. announced financial results for its fiscal second quarter ended March 31, 2020. The company is hosting a conference call at 4:30 p.m. EDT to discuss results.

May 7, 2020
·
6 min read
Pharm Country

AngioDynamics to Present at the UBS Virtual Global Healthcare Conference

AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the UBS Virtual Global Healthcare Conference at 9:10 a.m.

May 7, 2020
·
1 min read
Business

Omnicell Reports First Quarter 2020 Results

Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced results for its first quarter ended March 31, 2020.

May 7, 2020
·
18 min read